Covidien (NYSE:COV) subsidiary Given Imaging landed a victory with FDA medical device regulators who agreed to downgrade the PillCam capsule endoscope to a lower-risk classification.
Endoscopic
Lombard Medical sinks on IPO day | MassDevice.com On Call
Medtronic touts Endurant stent graft data
Covidien lands FDA OK for camera-equipped feeding tube
IPO: Stent graft maker Trivascular Tech. jumps on opening day
Trivascular Technologies (NSDQ:TRIV) shares made a good showing on their first day on the Nasdaq stock exchange, having gained 15% by about 4 p.m. EST.
Report: Covidien pays $100M for New Wave Surgical
Lombard Medical tables U.S. IPO
Lombard Medical Technologies (LON:LMT) said today that it’s tabling a planned initial public offering on the NASDAQ exchange due to adverse conditions in the U.S. stock market.
TriVascular Technologies sets price range for $98M IPO
TriVascular Technologies said it could raise as much as $98 million from its planned initial public offering after setting the per-share price range at $13-$15.
That would set the top end of the 6.5-million-share offering at $97.5 million, or $84.5 million at the low end.
Lombard Medical sets range for $55m – $65M IPO
Lombard Medical Technologies (LON:LMT) today set the range for its forthcoming U.S. initial public offering, saying it plans to price its shares between $15 apiece and $18.
Covidien’s Barrx ablation system stems progression of esophagus disease, study says
Invendo Medical raises $28M for single-use colonoscope
Invendo Medical said it raised a $28 million (€20.3 million) funding round for its single-use colonoscopy system led by new backer Xeraya Capital.
Kissing, Germany, and New York-based Invendo said a German Family Office also joined the round, which included existing investors TVM Capital, Wellington Partner, 360° Capital and its founders.